
Sona Pharma’s Q3 2025 Financials: A Playful Peek into Their Healthy Profits!
Sonoma Pharmaceuticals’ Q3 Financial Results: A 14% Revenue Growth and Positive Cash Flow Sonoma Pharmaceuticals, a pioneering healthcare company specializing in stabilized hypochlorous acid (HOCl) products, recently unveiled its financial performance for the third quarter and nine months ended December 31, 2024. The company reported impressive growth, with a 14% increase in revenues compared to…